FCM
Farallon Capital Management Portfolio holdings
AUM
$17.7B
1-Year Est. Return
25.69%
1 Year Est. Return
+25.69%
AUM
$21.8B
AUM Growth
+$3.52B
(+19%)
Holding
163
Top Buys
| 1 | +$3.4B | |
| 2 | +$666M | |
| 3 | +$223M | |
| 4 |
Thermo Fisher Scientific
TMO
|
+$141M |
| 5 |
AZEK
The AZEK Co
AZEK
|
+$109M |
Top Sells
| 1 | +$816M | |
| 2 | +$403M | |
| 3 | +$286M | |
| 4 |
Microsoft
MSFT
|
+$268M |
| 5 |
Intuit
INTU
|
+$239M |
Sector Composition
| 1 | Healthcare | 35.61% |
| 2 | Technology | 14.22% |
| 3 | Financials | 9.81% |
| 4 | Communication Services | 7.87% |
| 5 | Industrials | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Protagonist Therapeutics
PTGX
$5.47B
| $341M | 1.44% |
6,172,006
+65,000
|
|
||
27
BridgeBio Pharma
BBIO
$14.4B
| $341M | 1.44% |
7,900,000
+2,169,000
|
|
||
28
New York Times
NYT
$10.4B
| $314M | 1.33% |
5,609,546
-3,322,567
|
|
||
29
Alphabet (Google) Class C
GOOG
$3.84T
| $313M | 1.32% |
1,761,840
+95,800
|
|
||
30
Analog Devices
ADI
$135B
| $303M | 1.28% |
1,272,200
-54,800
|
|
||
31
CBRE Group
CBRE
$48.1B
| $296M | 1.25% |
2,113,138
-382,562
|
|
||
32
Wabtec
WAB
$36.6B
| $274M | 1.16% |
1,308,198
-299,900
|
|
||
33
McKesson
MCK
$100B
| $231M | 0.97% |
314,600
-237,900
|
|
||
34
Woodward
WWD
$18.1B
| $224M | 0.95% |
914,673
-505,027
|
|
||
35
Agios Pharmaceuticals
AGIO
$1.6B
| $192M | 0.81% |
5,767,466
+67,000
|
|
||
|
VRNA
36
DELISTED
Verona Pharma
VRNA
| $171M | 0.72% |
1,810,000
+725,011
|
|
||
|
AZEK
37
DELISTED
The AZEK Co
AZEK
| $171M | 0.72% |
3,141,400
+2,001,400
|
|
||
38
Beam Therapeutics
BEAM
$2.94B
| $170M | 0.72% |
10,013,111
+85,000
|
|
||
39
Crinetics Pharmaceuticals
CRNX
$4.5B
| $134M | 0.56% |
4,646,098
+41,000
|
|
||
40
Visa
V
$631B
| $110M | 0.46% |
308,810
-165,400
|
|
||
|
CHX
41
DELISTED
ChampionX
CHX
| $105M | 0.45% |
4,245,000
+1,340,000
|
|
||
42
GE HealthCare
GEHC
$37.6B
| $97.9M | 0.41% |
1,322,000
+785,000
|
|
||
43
Tenet Healthcare
THC
$18.6B
| $93.1M | 0.39% |
+529,000
|
|
||
44
Encompass Health
EHC
$11.4B
| $86.8M | 0.37% |
708,000
+89,000
|
|
||
45
Mastercard
MA
$487B
| $85.5M | 0.36% |
152,071
-49,300
|
|
||
46
Cardinal Health
CAH
$47.3B
| $76.3M | 0.32% |
454,000
+181,000
|
|
||
47
New Oriental
EDU
$8.16B
| $62.3M | 0.26% |
1,155,150
-150,000
|
|
||
|
BBNX
48
Beta Bionics
BBNX
$1.33B
| $61.2M | 0.26% |
4,203,920
+871,700
|
|
||
|
CNTA
49
Centessa Pharmaceuticals
CNTA
$4.36B
| $59.5M | 0.25% |
4,529,318
+195,000
|
|
||
|
AMED
50
DELISTED
Amedisys
AMED
| $56.6M | 0.24% |
575,000
+50,000
|
|